Is there a clinical association of vancomycin MIC Creep, agr Group II Locus, and treatment failure in MRSA bacteremia?

Diagnostic Molecular Pathology

Volumn 20, Issue 3, 2011, Pages 184-188

  De Sanctis, Jorgelina T ^a   Swami, Aditi ^a   Sawarynski, Kara ^a   Gerasymchuk, Ludmyla ^a   Powell, Kim ^a   Robinson Dunn, Barbara ^a   Carpenter, Christopher F ^a   Sims, Matthew D ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

agr group locus; MIC creep; MRSA; vancomycin treatment failure

Indexed keywords

COTRIMOXAZOLE; DAPTOMYCIN; LINEZOLID; RIFAMPICIN; VANCOMYCIN;

AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EXPOSURE; EPSILOMETER TEST; FEMALE; GENE LOCUS; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; REGULATOR GENE; SURVIVAL; TREATMENT FAILURE;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; TRANS-ACTIVATORS; TREATMENT FAILURE; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 80052273656     PISSN: 10529551     EISSN: 15334066     Source Type: Journal    
DOI: 10.1097/PDM.0b013e318208fc47     Document Type: Article

References (17)

1. Steinkraus G,White R, Friedrich L. Vancomycin MIC creep in nonvancomycin- intermediate Staphylococcus aureus (VISA), vancomycin- susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. J Antimicrob Chemother. 2007;60:788-794. (Pubitemid 47434257)
2. Sakoulas G, Moellering RC Jr, Eliopoulos GM. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy. Clin Infect Dis. 2006; 42(suppl 1):S40-S50. (Pubitemid 41832064)
3. Moise-Broder PA, Sakoulas G, Eliopoulos GM, et al. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin Infect Dis. 2004;38:1700-1705. (Pubitemid 38781661)
4. Papakyriacou H, Vaz D, Simor A, et al. Molecular analysis of the accessory gene regulator (agr) locus and balance of virulence factor expression in epidemic Methicillin-resistant Staphylococcus aureus. J Infect Dis. 2000;181:990-1000. (Pubitemid 30194483)
5. Sakoulas G, Moise-Broder PA, Schentag J, et al. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 2004;42:2398-2402. (Pubitemid 38747480)
6. Neoh HM, Hori S, Komatsu M, et al. Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections. Ann Clin Microbiol Antimicrob. 2007;6:13.
7. Deresinski S. Vancomycin heteroresistance and methicillin-resistant Staphylococcus aureus. J Infect Dis. 2009;199:605-609.
8. Hiramatsu K, Hanaki H, Ino T, et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother. 1997;40:135-136. (Pubitemid 27341646)
9. Miller D, Urdaneta V, Weltman A, et al. Staphylococcus aureus resistant to vancomycinFUnited States, 2002. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2002;51:565-567.
10. Rose WE, Rybak MJ, Tsuji BT, et al. Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function. J Antimicrob Chemother. 2007;59:1190.
11. Yoon HJ, Choi JY, Lee K, et al. Accessory gene regulator group polymorphisms in methicillin-resistant Staphylococcus aureus: An association with clinical significance. Med J. 2007;48:176-183. (Pubitemid 46711746)
12. Hidayat LK, Hsu DI, Quist R, et al. High dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: Efficacy and toxicity. Arch Intern Med. 2006;166:2138-2144. (Pubitemid 44631403)
13. Chua T, Moore CL, Perri MB, et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit. J Clin Microbiol. 2008;46:2345-2352.
14. Vaudaux P, Huggler E, Bernard L, et al. Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus. Antimicrob Agents Chemother. 2010;54: 3861-3870.
15. Novick RP. Pathogenicity factors and their regulation. In: Fischetti VA, Novick RP, Ferretti JJ, et al. editors. Gram-positive pathogens. Washington, DC: ASM Press; 2000; pp. 392-407.
16. Manago K, Nishi J, Wakimoto N, et al. Biofilm formation by accessory gene regulator typing of methicillin-resistant Staphylococcus aureus during infection and colonization. Infect Contol Hosp Epidemiol. 2006;27:188-190. (Pubitemid 43384767)
17. Tsuji BT, Rybak MJ, Lau KL, et al. Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 2007;51:1089-1091. (Pubitemid 46355301)